Books: The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

  • Gordon S
N/ACitations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Includes index. "The term 'deprescribing' originates from geriatric medicine where polypharmacy in frail patients can cause more harm than benefit. Deprescribing is increasingly recognised to be a key component of good prescribing - reducing doses when they are too high, and stopping medications when they are no longer needed. This process cannot occur in a vacuum of theoretical concerns but should take into account the patient's health, current level of functioning and, importantly, their values and preferences. Deprescribing seeks to apply best practice in prescribing to the process of stopping a medication. It requires the same skill and experience as for the process of prescribing from prescribers, as well as support from pharmacists and other healthcare staff to get the best results. Importantly, it should place patients at the centre of the process to ensure medicines optimisation"-- Provided by publisher. Chapter 1: Introduction to Deprescribing Psychiatric Medications -- Chapter 2: Safe Deprescribing of Antidepressants -- Chapter 3: Safe Deprescribing of Benzodiazepines and Z-drugs -- Chapter 4: Safe Deprescribing of Gabapentinoids.

Cite

CITATION STYLE

APA

Gordon, S. (2024). Books: The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs. British Journal of General Practice, 74(745), 369–370. https://doi.org/10.3399/bjgp24x739029

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free